ITGA2B and non-small cell lung carcinoma: Moreover, the strong expression levels of ITGA2B were found to be significantly higher in TEPs from NSCLC patients, and its use as a diagnostic marker proved to have high sensitivity and specificity, making it a promising marker to diagnose early-stage NSCLC [83].